- Products & Services
- Knowledge Base
NEW YORK, NY, July 04, 2020 /24-7PressRelease/ -- Dr. Jeffrey S. Borer is a Professor of Medicine, Cell Biology, Radiology, Public Health and Surgery at the State University of New York Downstate University of the Health Sciences (and Adjunct Professor of Cardiovascular Medicine in Cardiothoracic Surgery at Weill Cornell Medicine). With 45 years of industry experience, Dr. Borer's knowledge and research is highly respected in the world of medicine. Graduating with a Bachelor of Arts from Harvard College, he then received a Doctor of Medicine Degree from Cornell University Medical College (now Weill Cornell Medicine) in 1969. He then undertook his Residency in Internal Medicine at Massachusetts General Hospital in Boston, followed by service as a Clinical Associate in the Cardiology Branch of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD.
Dr. Borer served as Chief Resident for the Intramural Branch of the NHLBI and then was awarded two prestigious Fellowships (the Glorney Raisbeck Fellowship in Medical Sciences from the New York Academy of Medicine and a Senior Fullbright-Hays Scholar award; he undertook the two fellowships simultaneously at Guy's Hospital (University of London). During this fellowship year, he completed the first clinical demonstration of nitroglycerin's utility in acute myocardial infarction in humans after his several years of preclinical studies at the NIH.
After completing this fellowship, Dr Borer returned to the NHLBI as a Senior Investigator, where he developed Stress Radionuclide Cineangiography, an achievement which transformed the practice of cardiology by enabling the first non-invasive assessment of cardiac function with exercise. This groundbreaking development enabled unmasking of previously inapparent cardiac disabilities and quantification of their severities.
Returning to Cornell, Dr. Borer performed extensive clinical service, teaching and research, his research being primarily focused on developing prognosticators for regurgitant heart valve diseases and assessing the effects of heart rate modification on clinical outcomes. He also carried out studies in coronary artery disease and heart failure.
A respected voice in the field, Dr. Borer has served as an advisor to the USFDA for 43 years, as chair of the CardioRenal Drugs Advisory Committee for 3 terms and of the Circulatory Devices Advisory Panel for one term. He was also a life sciences Advisor to NASA for 24 years and previously served as a board member to several national professional societies, including the Heart Valve Society of America (2004-2014) of which he was the founding president.
Currently, Dr. Borer is Chair of the Cardiovascular Devices Subcommittee of the International Standardization Organization (ISO) which sets standards for manufacture (and approval) of devices, such as heart valve replacements, for countries outside of the US.
Dr. Borer has published more than 500 full-length scientific papers/chapters and 8 books. He was also the Editor-in-Chief of the journal CARDIOLOGY, one of the oldest peer-reviewed cardiology journals in the world, from 2005 to 2018, as well as a member of the editorial boards of numerous other major journals. His research has been supported by the National Institutes of Health, the American Heart Association and, for many years, by several large private foundations.
Dr. Borer has received many awards for his outstanding contributions to cardiology, most recently including the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who in 2018. In 2018 he was also selected for a Lifetime Achievement Award by the International Association of Top Professionals (IAOTP), who named him the Top Professor of the Year in Medicine. Additionally, in 2018 he received the Kanu Chatterjee Lifetime Achievement Award for Contributions to Cardiovascular Medicine from the International Academy of Cardiology, and in 2014 he received the Public Service Medal of NASA.
Outside of his commitments as a Professor at the State University of New York (and at Cornell), Dr. Borer enjoys visiting museums, physical fitness and attending theatre, ballet, opera, and sporting events. Additionally, he has maintained his affiliations with many industry organizations, associations, committees, and societies throughout his impressive career. In the future, Dr. Borer plans to continue his work in the field of cardiology, contributing his knowledge and experience to his professional and local communities.
# # #